In the Matter of the Estate of Galatis

36 N.E.3d 1247, 88 Mass. App. Ct. 273
CourtMassachusetts Appeals Court
DecidedSeptember 9, 2015
DocketAC 14-P-579
StatusPublished
Cited by1 cases

This text of 36 N.E.3d 1247 (In the Matter of the Estate of Galatis) is published on Counsel Stack Legal Research, covering Massachusetts Appeals Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In the Matter of the Estate of Galatis, 36 N.E.3d 1247, 88 Mass. App. Ct. 273 (Mass. Ct. App. 2015).

Opinions

Milkey, J.

On January 15, 2000, Charles P. Galatis, then seventy-six years old, was admitted to Massachusetts General Hospital (MGH). Once admitted, he was diagnosed with stage IV lung cancer, and over the ensuing weeks he suffered a rapid over-all decline in his physical and mental condition. Galatis remained hospitalized,1 and he died on February 25, 2000.

On February 9, 2000, Galatis executed a document purporting to be his will. The executor named in the will formally presented it for probate, joined by the will’s principal beneficiary, the town of Skiathos, Greece.2 Two of the decedent’s cousins contested the [274]*274will. After a ten-day trial, a Probate and Family Court judge declined to allow the will, because she found that Galatis lacked testamentary capacity on February 9. Because that finding is amply supported by record evidence, we affirm.

Background. The judge made 559 factual findings that totaled seventy-one pages. We summarize those findings, almost all of which are unchallenged, and highlight the facts still in dispute. See Rempelakis v. Russell, 65 Mass. App. Ct. 557, 559 (2006).

1. Galatis’s background medical conditions. By the time Galatis was admitted to MGH, he already suffered from a long list of medical problems including diabetes, hyperkalemia (excess potassium in the blood), and major depression. For such problems, Galatis was taking twelve different prescribed medications, including the antidepressant Elavil, and two different narcotics for pain relief. The symptoms of anxiety and depression worsened following his diagnosis with metastatic lung cancer. He therefore was prescribed a second antidepressant, and the dosages for both antidepressants subsequently were increased. His painkillers also were aggressively increased, and he was placed on a self-administered morphine drip beginning on February 8.

2. The February 1 document. When he entered MGH, Galatis apparently had no existing will. At some point during his initial hospitalization, he asked a friend, Steven Damaskos, to record his thoughts regarding the disposition of his property. Damaskos wrote down individual names that Galatis provided to him, followed by specific amounts of money they were to receive. Damaskos then transcribed the information onto a will template form he found through an Internet search, and Galatis signed the resulting document on February 1, 2000. As discussed below, although the February 1 document was admitted in evidence at the trial on the February 9 will, it was not itself offered for probate prior to the conclusion of that trial.

3. Differences between the February 1 document and the February 9 will. An attorney brought in by Damaskos to prepare a proper will for Galatis was given the February 1 document as a starting point. The end product was the will executed by Galatis on February 9, 2000. The estate plan delineated in that will is similar in most material respects to that contained in the earlier [275]*275document. Both documents provided for the creation of a charitable -trust administered by a foundation in Skiathos, the corpus of which\would consist of Galatis’s real estate assets in Greece. Unsurprisingly, the later document drafted by the attorney generally is a more developed product than the earlier one produced by Damaskos, and many of the differences could best be described as refinements or minor modifications to the earlier plan. For example, the February 9 will provided for the disposition of certain personal property not enumerated in the February 1 document. However, the February 9 will also included some curious additions and omissions. The will included one beneficiary who — according to uncontradicted testimony — apparently does not exist, and the residuary clause included in the February 1 document was omitted (even though — again, according to uncontra-dicted testimony — the will did not otherwise dispose of all of Galatis’s estate).3

4. The events of February 8, 2000. Sometime in the late afternoon of February 8, 2000 (the day before the will signing), Galatis was administered a dose of Ativan for his anxiety symptoms. Apparently as a result of an adverse reaction to the Ativan, Galatis became somnolent and developed a facial droop. He exhibited slurred speech, drowsiness, and inability to pay attention, and he required constant stimulation to generate answers to questions. After it was observed that his arms were flopping, he was diagnosed with asterixis, which is indicative of central nervous system impairment. These symptoms also led to Galatis being diagnosed with the underlying brain condition encephalopathy.

5. The extent of Galatis’s temporary recovery. On the evening of February 8, Galatis was given a drug to try to reverse the effects of the Ativan. Both sides agree that the administration of this drug (the antidote) had some beneficial effects. They differ sharply, however, on the import of the Ativan episode with regard to Galatis’s mental state when he signed the will the following day. The will proponents sought to portray the administration of the antidote as allowing Galatis to make a dramatic recovery [276]*276through which he regained sufficient capacity to execute the will. The will contestants asserted that while the reaction to the Ativan may have exacerbated Galatis’s mental condition on February 8, he by that time was already suffering from encephalopathy, which was impairing his cognitive and motor functions.

6. The will contestant witnesses. The will contestants supported their case with expert opinion testimony from Dr. Marc Whaley, a forensic psychiatrist. Dr. Whaley testified from his review of the medical records that Galatis had exhibited symptoms of encephalopathy (albeit less severe) in the days prior to the Ativan reaction.4 He also opined that even though Galatis may have shown some improvement through the administration of the antidote, the underlying encephalopathy would not have abated. According to him, a person with encephalopathy suffers from a loss of ability to communicate, remain oriented, think logically, solve problems, and remember information.

The will contestants also called Dr. John Stoeckle, the attending physician who directed Galatis’s care at MGH. Dr. Stoeckle was particularly well-suited to offer an opinion regarding Galatis’s mental capacity because he had served as Galatis’s primary care physician for the last fifteen years of his life. In addition, Dr. Stoeckle had examined Galatis throughout his hospitalization, including multiple times each day on February 6 through 10. Consistent with the testimony of Dr. Whaley, Dr. Stoeckle opined that Galatis suffered from encephalopathy and that as of February 9, this condition impaired his ability to think clearly, orient himself, speak and communicate, think logically, solve problems, and remember information.

7. The contemporaneous hospital records. The hospital records from February 9 (the day Galatis signed the will) provided some fodder for each side. A nurse’s progress note from 6:00 a.m.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In the Matter of the Estate of Jasiul
Massachusetts Appeals Court, 2026
In the Matter of the Estate of Urban
Massachusetts Appeals Court, 2023

Cite This Page — Counsel Stack

Bluebook (online)
36 N.E.3d 1247, 88 Mass. App. Ct. 273, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-the-matter-of-the-estate-of-galatis-massappct-2015.